STOCK TITAN

Harvard Bioscience Schedules Fourth Quarter 2021 Earnings Conference Call for March 8, 2022 at 8:00 AM ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) is set to announce its fourth-quarter financial results for the period ending December 31, 2021, on March 8, 2022, prior to market opening. The company will hold a conference call at 8:00 a.m. Eastern Time to discuss these results. Investors can participate by dialing the provided numbers or via the live webcast accessible through their website. Harvard Bioscience specializes in developing technologies for fundamental research and drug development, serving various sectors from academia to pharmaceuticals.

Positive
  • None.
Negative
  • None.

HOLLISTON, Mass., Feb. 21, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2021 before the market opens on March 8, 2022, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

You can access the live conference call by dialing the following phone numbers: toll-free 1 (877) 303-7611 or international 1 (970) 315-0445 and referencing the conference ID #1749525.

The conference call will be simultaneously webcast and can be accessed through the Harvard Bioscience website. To listen to the webcast, go to http://investor.harvardbioscience.com/ – Events & Presentations.

Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.

About Harvard Bioscience

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe and China, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Investor Contact
Michael Rossi
Chief Financial Officer
(508) 893-8999
mrossi@harvardbioscience.com 


FAQ

When will Harvard Bioscience announce its financial results for Q4 2021?

Harvard Bioscience will announce its financial results for the fourth quarter of 2021 on March 8, 2022.

What time is the conference call for Harvard Bioscience's Q4 results?

The conference call for Harvard Bioscience's Q4 results will be held at 8:00 a.m. Eastern Time.

How can I access the live conference call for HBIO's financial results?

You can access the live conference call by dialing 1 (877) 303-7611 (toll-free) or 1 (970) 315-0445 (international) and referencing conference ID #1749525.

Where can I listen to the webcast of Harvard Bioscience's financial results?

The webcast can be accessed through the Investor Relations section of Harvard Bioscience’s website.

Harvard Bioscience Inc

NASDAQ:HBIO

HBIO Rankings

HBIO Latest News

HBIO Stock Data

92.25M
40.23M
7.77%
76.04%
0.86%
Medical Instruments & Supplies
Laboratory Analytical Instruments
Link
United States of America
HOLLISTON